Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis

Xueqiong Xun(Qujing Normal University), Huiyong Hu(Qujing Normal University), Ruikang Liu(Nankai University), Saroj Rai(Dubai Medical College), Baowen Zhang(Huazhong University of Science and Technology), Jun Ai(Qujing Normal University), Yeming Zhou(Tongji Hospital), Fuhui Feng(Qujing Normal University)
Frontiers in Pharmacology
January 30, 2023
Cited by 5


Related Papers